DOW
loading...
NASDAQ
loading...
S&P
loading...




Action Alerts PLUS
RealMoney Silver
Market Movers
Stocks Under $10
Options Alerts
Breakout Stocks
View All


Now, enjoy the good life every day!

RSSRSS FEEDS
PODPODCASTS


Opinion: Aaron Pressman
Print This Story

Why Buffett Is Smiling

By Aaron Pressman
Senior Market Columnist

2/1/2005 4:44 PM EST
 
 Market Overview NEUTRAL
  • Buffett's stakes in Gillette and Amex have risen about $1 billion in the past week.
  • But the deal surge is putting downward pressure on the corporate bond market.
  • Plus, rethinking the financial 'supermarket.'



February's just getting started but it's already a bonanza for legendary investor Warren Buffett. His stakes in Gillette (G - commentary - Cramer's Take) and American Express (AXP - commentary - Cramer's Take) have appreciated about $1 billion in the past few days.

Buffett even lent his name and credibility to the Gillette acquisition, saying he'd be increasing his stake. All the M&A activity, along with a bevy of good economic data, have surely helped stocks pick up some ground lost in January. And Buffett's not the only winner. Amex was the top holding of Chris Davis' Davis Financial Fund and Berkshire Hathaway (BRK.A - commentary - Cramer's Take) was No. 7, as of the end of September. The fund, up 1% in the past few days, also owns a slug of insurance divesting Citicorp (C - commentary - Cramer's Take), which rose 0.9% to $49.48 Tuesday.

Citi's rise helped the Dow Jones Industrial Average gain 62 points, or 0.6%, to 10,551.94, while fellow financial component American Express gained 6% after it announced it would spin off its financial advisory unit. The S&P 500 rose 0.7% to 1189.41 and the Nasdaq Composite added 0.3% to close at 2068.70.

Among other deals coming together over the past week, MetLife (MET - commentary - Cramer's Take) agreed to buy Citicorp's life insurance and annuity business for $11.5 billion; SBC (SBC - commentary - Cramer's Take) agreed to pick up its former parent, AT&T (T - commentary - Cramer's Take) for $16 billion, and; Eastman Kodak (EK - commentary - Cramer's Take) snapped up Canadian printer Creo for $1 billion.

The deal surge is putting downward pressure on the corporate bond market, where prices are considered historically rich when compared with Treasury bonds. Credit-rating agencies are reviewing bond ratings of Procter & Gamble, Kodak and SBC for possible downgrades in the wake of their announced acquisitions. SBC's bonds due in 30 years, for example, yielded 5.83% on Tuesday, up from 5.76% at the beginning of January, according to the Nasdaq Trace database. Over the same period, the yield on the 30-year Treasury note has decreased to 4.59% from 4.82%.

Go to NEXT PAGE


 RELATED STORIES

Adam Feuerstein
Cell Therapeutics' Deal Begs $18 Million Questions
12/21/2004 7:44 AM EST
The company's been oddly promotional throughout the Stellar 3 study, and this deal adds to the wonder.

Adam Feuerstein
Biotech Investors: Mark Your 2005 Calendars
1/5/2005 8:15 AM EST
Here's a list of events that could dictate trading. Plus, Adam Feuerstein's new challenge.



In keeping with TSC's editorial policy, Pressman doesn't own or short individual stocks. He also doesn't invest in hedge funds or other private investment partnerships. He invites you to send your feedback.
Write us!
Order reprints of TSC articles. Top



Brokerage Partners


TheStreet Premium Services
Jim Cramer
Jim Cramer's Action Alerts PLUS
Now any level of investor can trade right alongside a Wall Street pro — and enjoy 24/7 access to his portfolio! Learn More
Doug Kass
RealMoney Silver
The genius of Doug Kass + 5 Premium Services = an unrivaled group of expert fundamental analysts, technical analysts, and Wall Street observers. Learn More
Don Dion
NEW! Don Dion's ETF Action
A concise two-step strategy for learning and trading in this increasingly lucrative area of investing. For all levels of investors! Learn More
David Peltier
Stocks Under $10
David Peltier is ready to help you find affordable stocks under $10. Because they're so inexpensive, the payout could be enormous! Learn More
Bryan Ashenberg
Breakout Stocks
Bryan Ashenberg combines sophisticated screening software with eagle-eye analysis to find small and mid-caps ready to break out! Learn More

Investor Relations | Privacy Policy | Terms of Use | Conflicts Policy | Corrections | Internet Index | Advertise | FAQ
Site Map | Who's Who | Reader Feedback | Employment | Contact Us
RSSSubscribe to our RSS Feed
© 1996- TheStreet.com, Inc. All rights reserved.
TheStreet.com's enterprise databases running Oracle are professionally monitored and managed by Pythian Remote DBA.